Biocell Center Corp. and the Caritas Christi Health Care network of hospitals launch a program to preserve stem cells from amniotic fluid.
Biocell Center Corp. and Caritas Christi Health Care inked a deal to start a cryopreservation service for amniotic fluid stem cells.
The Italian biotech firm, which has its U.S. headquarters in Medford, Mass., and New England's largest community hospital network will use Biocell's method of preserving stem cells obtained during routine second-trimester amniocentesis procedures. The mesenchymal stem cells can be stored for decades and are believed to hold the key to treating or even eventually curing a raft of diseases. Parents can opt to preserve the cells for use in the event of future illness for themselves or their children.
Transcatheter aortic valve implantation proves successful in reinforcing failed valve prosthetics,...
A rare but deadly genetic mutation that prevents the body from absorbing protein can be set off by...
Ohio-based medical device makers meet with local legislators to discuss efforts to repeal the...
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...